Prudential Financial
RYTM icon

Prudential Financial’s Rhythm Pharmaceuticals RYTM Stock Holding History

Prudential Financial’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.68M Buy
69,145
+38,955
+129% +$3.52M 0.01% 812
2026
Q1 		$2.63M Sell
30,190
-22,955
-43% -$2.23M ﹤0.01% 1203
2025
Q4 		$5.69M Sell
53,145
-19,865
-27% -$2.11M 0.01% 856
2025
Q3 		$7.37M Buy
73,010
+65,915
+929% +$6.12M 0.01% 748
2025
Q2 		$423K Buy
7,095
+2,740
+63% +$168K ﹤0.01% 1990
2025
Q1 		$243K Buy
4,355
+200
+5% +$11.1K ﹤0.01% 2021
2024
Q4 		$234K Sell
4,155
-104
-2% -$5.75K ﹤0.01% 2053
2024
Q3 		$223K Buy
+4,259
New +$204K ﹤0.01% 2481
2022
Q1 		– Sell
-46,400
Closed -$463K – 2683
2021
Q4 		$463K Buy
46,400
+23,648
+104% +$266K ﹤0.01% 2229
2021
Q3 		$297K Sell
22,752
-8,221
-27% -$126K ﹤0.01% 2329
2021
Q2 		$607K Buy
+30,973
New +$643K ﹤0.01% 2065

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Prudential Financial's RYTM Position: Q2 2026 in Review

Prudential Financial increased its Rhythm Pharmaceuticals (RYTM) stake by 129% in Q2 2026, buying an estimated $3.52M and bringing the position to 69,145 shares worth $7.68M. The position accounts for 0.01% of the portfolio, ranked #812.

Prudential Financial first reported a position in RYTM in Q2 2021 and has held it in 11 quarters since. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Prudential Financial held 69,145 shares of Rhythm Pharmaceuticals worth $7.68M as of Q2 2026.
  • Prudential Financial bought 38,955 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $3.52M.
  • Rhythm Pharmaceuticals made up 0.01% of Prudential Financial's portfolio in Q2 2026, its #812 holding.
  • Prudential Financial first reported a position in Rhythm Pharmaceuticals in Q2 2021 and has held it in 11 quarters since.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.